抗凝血酶(AT)活性蛋白
Active Antithrombin (AT)
AT3; ATIII; SERPINC1; Anti-Thrombin Antibodies; Serpin Peptidase Inhibitor Clade C Member 1; Coding Sequence Signal Peptide Antithrombin Part 1
- 編號APC313Hu61
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 緩沖液成份磷酸鹽緩沖液（pH7.4，含有 0.01% SKL, 1mM DTT, 5% Trehalose和Proclin300.）
- 性狀凍干粉
- 純度> 95%
- 等電點6.1
- 應用Cell?culture;?Activity?Assays.
- 下載 英文說明書 中文說明書
- 規格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 2160 ¥ 5400 ¥ 10800 ¥ 32400 ¥ 81000
- 欲了解實際交易價格和更多情況，請與當地經銷商聯系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
SDS-PAGE圖
-
通過ISO 9001、ISO 13485質量體系認證
活性實驗
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩定性
熱穩定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產生。保質期內，在適當的條件下存儲，損失率低于5%。
增值服務
相關產品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| NPC313Hu01 | 抗凝血酶(AT)天然蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APC313Hu01 | 抗凝血酶(AT)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPC313Hu03 | 抗凝血酶(AT)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| EPC313Hu61 | 抗凝血酶(AT)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPC313Hu01 | 抗凝血酶(AT)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPC313Hu02 | 抗凝血酶(AT)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APC313Hu61 | 抗凝血酶(AT)活性蛋白 | Cell?culture;?Activity?Assays. |
| PAC313Hu01 | 抗凝血酶(AT)多克隆抗體 | WB; IHC; ICC; IP. |
| PAC313Hu02 | 抗凝血酶(AT)多克隆抗體 | WB; IHC; ICC; IP. |
| PAC313Hu03 | 抗凝血酶(AT)多克隆抗體 | WB; IHC; ICC; IP. |
| LAC313Hu81 | 抗凝血酶(AT)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| LAC313Hu71 | 抗凝血酶(AT)多克隆抗體(生物素標記) | WB; IHC; ICC. |
| MAC313Hu21 | 抗凝血酶(AT)單克隆抗體 | WB; IHC; ICC; IP. |
| MAC313Hu27 | 抗凝血酶(AT)單克隆抗體 | WB,IHC |
| MAC313Hu29 | 抗凝血酶(AT)單克隆抗體 | WB; IHC; ICC; IP. |
| MAC313Hu23 | 抗凝血酶(AT)單克隆抗體 | WB; IHC; ICC; IP. |
| MAC313Hu24 | 抗凝血酶(AT)單克隆抗體 | WB; IHC; ICC; IP. |
| MAC313Hu26 | 抗凝血酶(AT)單克隆抗體 | WB; IHC; ICC; IP. |
| MAC313Hu22 | 抗凝血酶(AT)單克隆抗體 | WB,IHC |
| MAC313Hu28 | 抗凝血酶(AT)單克隆抗體 | WB; IHC; ICC; IP. |
| MAC313Hu25 | 抗凝血酶(AT)單克隆抗體 | WB; IHC; ICC; IP. |
| FAC313Hu02 | 抗抗凝血酶(AT)單克隆抗體 | FCM |
| FAC313Hu04 | 抗抗凝血酶(AT)單克隆抗體 | FCM |
| FAC313Hu08 | 抗抗凝血酶(AT)單克隆抗體 | FCM |
| LAC313Hu72 | 抗凝血酶(AT)單克隆抗體(生物素標記) | WB; IHC; ICC. |
| LAC313Hu82 | 抗凝血酶(AT)單克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
| SEC313Hu | 抗凝血酶(AT)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| SCC313Hu | 抗凝血酶(AT)檢測試劑盒(化學發光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| LMC313Hu | 抗凝血酶(AT)等多因子檢測試劑盒(流式熒光發光法) | FLIA Kit for Antigen Detection. |
| KSC313Hu01 | 抗凝血酶(AT)檢測試劑盒DIY材料(酶聯免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
| 雜志 | 參考文獻 |
| Thromb Res | Thalidomide and multiple myeloma serum synergistically induce a hemostatic imbalance in endothelial cells in vitro [PubMed: 25840743] |
| Neurotherapeutics | iTRAQ-Based Quantitative Proteomics Reveals the New Evidence Base for Traumatic Brain Injury Treated with Targeted Temperature Management [pubmed:29247448] |
| Journal of?Clinical?and Aesthetic Dermatology | Detection of Angiotensin II and AT1 Receptor Concentrations in Keloid and Hypertrophic Scar. [] |
| 博士論文 | An Agile Approach to Novel Recombinant Antithrombin Production for use in Biologics Development [] |
留言咨詢
